Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb EPS - Earnings per Share 2010-2023 | BMY

Bristol Myers Squibb annual and quarterly earnings per share history from 2010 to 2023. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Bristol Myers Squibb EPS for the quarter ending June 30, 2023 was $0.99, a 50% increase year-over-year.
  • Bristol Myers Squibb EPS for the twelve months ending June 30, 2023 was $3.76, a 24.92% increase year-over-year.
  • Bristol Myers Squibb 2022 annual EPS was $2.95, a 5.45% decline from 2021.
  • Bristol Myers Squibb 2021 annual EPS was $3.12, a 178.2% decline from 2020.
  • Bristol Myers Squibb 2020 annual EPS was $-3.99, a 298.51% decline from 2019.
  
Bristol Myers Squibb Annual EPS
2022 $2.95
2021 $3.12
2020 $-3.99
2019 $2.01
2018 $3.01
2017 $0.61
2016 $2.65
2015 $0.93
2014 $1.20
2013 $1.54
2012 $1.16
2011 $2.16
2010 $1.79
2009 $5.34
Bristol Myers Squibb Quarterly EPS
2023-06-30 $0.99
2023-03-31 $1.07
2022-12-31 $0.95
2022-09-30 $0.75
2022-06-30 $0.66
2022-03-31 $0.59
2021-12-31 $1.07
2021-09-30 $0.69
2021-06-30 $0.47
2021-03-31 $0.89
2020-12-31 $-4.43
2020-09-30 $0.82
2020-06-30 $-0.04
2020-03-31 $-0.34
2019-12-31 $-0.73
2019-09-30 $0.83
2019-06-30 $0.87
2019-03-31 $1.04
2018-12-31 $0.71
2018-09-30 $1.16
2018-06-30 $0.23
2018-03-31 $0.91
2017-12-31 $-1.40
2017-09-30 $0.51
2017-06-30 $0.56
2017-03-31 $0.94
2016-12-31 $0.53
2016-09-30 $0.72
2016-06-30 $0.69
2016-03-31 $0.71
2015-12-31 $-0.12
2015-09-30 $0.42
2015-06-30 $-0.08
2015-03-31 $0.71
2014-12-31 $0.01
2014-09-30 $0.43
2014-06-30 $0.20
2014-03-31 $0.56
2013-12-31 $0.43
2013-09-30 $0.42
2013-06-30 $0.32
2013-03-31 $0.37
2012-12-31 $0.57
2012-09-30 $-0.43
2012-06-30 $0.38
2012-03-31 $0.64
2011-12-31 $0.51
2011-09-30 $0.56
2011-06-30 $0.52
2011-03-31 $0.57
2010-12-31 $0.28
2010-09-30 $0.55
2010-06-30 $0.53
2010-03-31 $0.43
2009-12-31 $4.05
2009-09-30 $0.48
2009-06-30 $0.49
2009-03-31 $0.32
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $119.538B $46.159B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $139.615B 14.69
Gilead Sciences (GILD) United States $91.295B 11.67
Vertex Pharmaceuticals (VRTX) United States $89.081B 26.25
Regeneron Pharmaceuticals (REGN) United States $87.749B 21.18
CSL (CSLLY) Australia $75.725B 0.00
GSK (GSK) United Kingdom $73.485B 9.97
Seagen (SGEN) United States $39.888B 0.00
Moderna (MRNA) United States $39.232B 38.04
Biogen (BIIB) United States $36.396B 15.48
Argenex SE (ARGX) Netherlands $27.675B 0.00
Horizon Therapeutics Public (HZNP) Ireland $26.616B 25.89
BioNTech SE (BNTX) Germany $26.347B 6.13
Genmab (GMAB) Denmark $22.539B 34.12
Alnylam Pharmaceuticals (ALNY) United States $21.614B 0.00
Illumina (ILMN) United States $21.200B 152.18
BeiGene (BGNE) Cayman Islands $16.885B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.219B 86.19
Incyte (INCY) United States $13.123B 32.00
Exact Sciences (EXAS) United States $11.852B 0.00
Legend Biotech (LEGN) United States $10.690B 0.00
Sarepta Therapeutics (SRPT) United States $10.600B 0.00
Bio-Techne Corp (TECH) United States $10.523B 37.52
Bio-Rad Laboratories (BIO.B) United States $10.324B 28.98
Verona Pharma American Depositary Share (VRNA) United Kingdom $9.764B 0.00
QIAGEN (QGEN) Netherlands $9.061B 19.11
Repligen (RGEN) United States $8.429B 57.70
Roivant Sciences (ROIV) United Kingdom $8.042B 0.00
Exelixis (EXEL) United States $6.966B 42.90
Swedish Orphan Biovitrum (BIOVF) Sweden $6.139B 19.81
Karuna Therapeutics (KRTX) United States $6.065B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $6.020B 0.00
Ascendis Pharma (ASND) Denmark $5.024B 0.00
Halozyme Therapeutics (HALO) United States $4.967B 16.73
Intra-Cellular Therapies (ITCI) United States $4.939B 0.00
Alkermes (ALKS) Ireland $4.637B 232.00
Apellis Pharmaceuticals (APLS) United States $4.584B 0.00
Immunovant (IMVT) United States $4.479B 0.00
Vaxcyte (PCVX) United States $4.453B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.614B 0.00
Insmed (INSM) United States $3.497B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.410B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.402B 0.00
Guardant Health (GH) United States $3.388B 0.00
Ginkgo Bioworks Holdings (DNA) United States $3.358B 0.00
Amicus Therapeutics (FOLD) United States $3.167B 0.00
Krystal Biotech (KRYS) United States $3.135B 0.00
Axsome Therapeutics (AXSM) United States $3.012B 0.00
Blueprint Medicines (BPMC) United States $2.944B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.902B 0.00
Denali Therapeutics (DNLI) United States $2.852B 0.00
Akero Therapeutics (AKRO) United States $2.639B 0.00
Intellia Therapeutics (NTLA) United States $2.626B 0.00
Cytokinetics (CYTK) United States $2.580B 0.00
Mirati Therapeutics (MRTX) United States $2.558B 0.00
Prothena (PRTA) Ireland $2.541B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.535B 0.00
Nuvalent (NUVL) United States $2.419B 0.00
Fortrea Holdings (FTRE) United States $2.413B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.361B 0.00
Zai Lab (ZLAB) China $2.316B 0.00
Certara (CERT) United States $2.261B 37.24
Structure Therapeutics (GPCR) United States $2.256B 0.00
Zealand Pharma (ZLDPF) Denmark $2.239B 0.00
Galapagos (GLPG) Belgium $2.231B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.154B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.943B 10.79
Dynavax Technologies (DVAX) United States $1.856B 20.01
Neumora Therapeutics (NMRA) United States $1.802B 0.00
Ventyx Biosciences (VTYX) United States $1.773B 0.00
Beam Therapeutics (BEAM) United States $1.773B 0.00
Bavarian Nordic (BVNRY) Denmark $1.662B 10.01
Arcellx (ACLX) United States $1.648B 0.00
Vericel (VCEL) United States $1.605B 0.00
Biohaven (BHVN) United States $1.586B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.520B 0.00
SpringWorks Therapeutics (SWTX) United States $1.512B 0.00
NeoGenomics (NEO) United States $1.488B 0.00
IDEAYA Biosciences (IDYA) United States $1.469B 0.00
CureVac (CVAC) Germany $1.410B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.363B 0.00
POINT Biopharma Global (PNT) United States $1.307B 14.21
Arcus Biosciences (RCUS) United States $1.271B 0.00
AbCellera Biologics (ABCL) Canada $1.267B 0.00
Myriad Genetics (MYGN) United States $1.265B 0.00
Celldex Therapeutics (CLDX) United States $1.241B 0.00
Vir Biotechnology (VIR) United States $1.232B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.227B 0.00
RayzeBio (RYZB) United States $1.160B 0.00
ANI Pharmaceuticals (ANIP) United States $1.146B 18.34
Mirum Pharmaceuticals (MIRM) United States $1.140B 0.00
Morphic Holding (MORF) United States $1.102B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.090B 29.30
89BIO (ETNB) United States $1.087B 0.00
Viking Therapeutics (VKTX) United States $1.077B 0.00
Tango Therapeutics (TNGX) United States $1.073B 0.00
Iovance Biotherapeutics (IOVA) United States $1.063B 0.00
Twist Bioscience (TWST) United States $1.054B 0.00
Merus (MRUS) Netherlands $1.052B 0.00
Apogee Therapeutics (APGE) United States $1.050B 0.00
MannKind (MNKD) United States $1.039B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.023B 0.00
Disc Medicine (IRON) United States $1.022B 0.00
Pliant Therapeutics (PLRX) United States $1.021B 0.00
Ligand Pharmaceuticals (LGND) United States $1.020B 22.60
Arvinas (ARVN) United States $1.012B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.999B 0.00
Geron (GERN) United States $0.979B 0.00
Northwest Biotherapeutics (NWBO) United States $0.977B 0.00
Replimune (REPL) United States $0.955B 0.00
Protagonist Therapeutics (PTGX) United States $0.934B 0.00
Revance Therapeutics (RVNC) United States $0.919B 0.00
Keros Therapeutics (KROS) United States $0.915B 0.00
ACELYRIN, INC (SLRN) United States $0.914B 0.00
Prime Medicine (PRME) United States $0.884B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.878B 0.00
MiMedx (MDXG) United States $0.871B 0.00
Kymera Therapeutics (KYMR) United States $0.859B 0.00
Pharming Group (PHGUF) Netherlands $0.848B 0.00
Pharming Group (PHAR) Netherlands $0.822B 0.00
Cogent Biosciences (COGT) United States $0.820B 0.00
Belite Bio (BLTE) United States $0.809B 0.00
Immatics (IMTX) Germany $0.797B 0.00
Inhibrx (INBX) United States $0.783B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.778B 0.00
Cytek Biosciences (CTKB) United States $0.757B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.756B 0.00
Adaptive Biotechnologies (ADPT) United States $0.755B 0.00
ADMA Biologics Inc (ADMA) United States $0.749B 0.00
REGENXBIO (RGNX) United States $0.725B 0.00
Novavax (NVAX) United States $0.724B 0.00
Sana Biotechnology (SANA) United States $0.711B 0.00
ImmunityBio (IBRX) United States $0.655B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.651B 12.89
Sinovac Biotech (SVA) China $0.644B 0.00
Ambrx Biopharma (AMAM) United States $0.642B 0.00
Travere Therapeutics (TVTX) United States $0.641B 0.00
Genelux (GNLX) United States $0.629B 0.00
HilleVax (HLVX) United States $0.627B 0.00
Viridian Therapeutics (VRDN) United States $0.615B 0.00
Kura Oncology (KURA) United States $0.614B 0.00
Avid Bioservices (CDMO) United States $0.603B 0.00
Pharma Mar (PHMMF) Spain $0.600B 0.00
Editas Medicine (EDIT) United States $0.598B 0.00
Tyra Biosciences (TYRA) United States $0.596B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.596B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.593B 0.00
PureTech Health (PRTC) United States $0.592B 0.00
Cabaletta Bio (CABA) United States $0.589B 0.00
WAVE Life Sciences (WVE) Singapore $0.578B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.574B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.573B 0.00
Vera Therapeutics (VERA) United States $0.570B 0.00
Allogene Therapeutics (ALLO) United States $0.530B 0.00
Alector (ALEC) United States $0.525B 0.00
Rapt Therapeutics (RAPT) United States $0.519B 0.00
Anavex Life Sciences (AVXL) United States $0.513B 0.00
Entrada Therapeutics (TRDA) United States $0.508B 0.00
AnaptysBio (ANAB) United States $0.489B 0.00
Repare Therapeutics (RPTX) Canada $0.474B 0.00
Olema Pharmaceuticals (OLMA) United States $0.465B 0.00
Avidity Biosciences (RNA) United States $0.463B 0.00
Biomea Fusion (BMEA) United States $0.459B 0.00
23andMe Holding (ME) United States $0.428B 0.00
Janux Therapeutics (JANX) United States $0.426B 0.00
Castle Biosciences (CSTL) United States $0.420B 0.00
Zymeworks (ZYME) United States $0.419B 2.21
Oculis Holding AG (OCS) Switzerland $0.413B 0.00
Liquidia Technologies (LQDA) United States $0.410B 0.00
Caribou Biosciences (CRBU) United States $0.409B 0.00
IGM Biosciences (IGMS) United States $0.392B 0.00
Agenus (AGEN) United States $0.391B 0.00
ITeos Therapeutics (ITOS) United States $0.377B 0.00
Mineralys Therapeutics (MLYS) United States $0.377B 0.00
Nautilus Biotechnology (NAUT) United States $0.376B 0.00
Scholar Rock Holding (SRRK) United States $0.374B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.371B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.370B 0.00
Edgewise Therapeutics (EWTX) United States $0.369B 0.00
Aerovate Therapeutics (AVTE) United States $0.369B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.363B 0.00
Icosavax (ICVX) United States $0.360B 0.00
Cullinan Oncology (CGEM) United States $0.348B 0.00
Amarin (AMRN) Ireland $0.345B 0.00
Precigen (PGEN) United States $0.332B 0.00
Aura Biosciences (AURA) United States $0.327B 0.00
Nurix Therapeutics (NRIX) United States $0.325B 0.00
Urogen Pharma (URGN) United States $0.325B 0.00
Bluebird Bio (BLUE) United States $0.322B 0.00
Coherus BioSciences (CHRS) United States $0.316B 0.00
Arbutus Biopharma (ABUS) United States $0.315B 0.00
AN2 Therapeutics (ANTX) United States $0.314B 0.00
MaxCyte (MXCT) United States $0.311B 0.00
Voyager Therapeutics (VYGR) United States $0.310B 3.11
ALX Oncology Holdings (ALXO) United States $0.309B 0.00
Terns Pharmaceuticals (TERN) United States $0.306B 0.00
Oric Pharmaceuticals (ORIC) United States $0.305B 0.00
UniQure (QURE) Netherlands $0.302B 0.00
Zura Bio (ZURA) United States $0.302B 0.00
Renovaro Biosciences (RENB) United States $0.299B 0.00
Apollomics (APLM) Taiwan $0.290B 0.00
Humacyte (HUMA) United States $0.284B 0.00
Erasca (ERAS) United States $0.284B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.282B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.281B 0.00
Nuvation Bio (NUVB) United States $0.276B 0.00
Anika Therapeutics (ANIK) United States $0.276B 0.00
MeiraGTx Holdings (MGTX) United States $0.271B 0.00
Third Harmonic Bio (THRD) United States $0.267B 0.00
Seres Therapeutics (MCRB) United States $0.264B 0.00
Ovid Therapeutics (OVID) United States $0.256B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.255B 0.00
Atea Pharmaceuticals (AVIR) United States $0.253B 0.00
Fulcrum Therapeutics (FULC) United States $0.245B 0.00
Compass Therapeutics (CMPX) United States $0.243B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.243B 0.00
DBV Technologies S.A (DBVT) France $0.241B 0.00
Kamada (KMDA) Israel $0.238B 18.28
Vanda Pharmaceuticals (VNDA) United States $0.238B 15.30
ScPharmaceuticals (SCPH) United States $0.234B 0.00
AC Immune (ACIU) Switzerland $0.231B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.225B 0.00
Inozyme Pharma (INZY) United States $0.224B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.222B 0.00
Lifecore Biomedical (LFCR) United States $0.217B 0.00
Inventiva S.A (IVA) France $0.213B 0.00
Immuneering (IMRX) United States $0.210B 0.00
Praxis Precision Medicines (PRAX) United States $0.210B 0.00
Innate Pharma S.A (IPHA) France $0.209B 0.00
Vigil Neuroscience (VIGL) United States $0.206B 0.00
Allakos (ALLK) United States $0.205B 0.00
2seventy Bio (TSVT) United States $0.205B 0.00
Akoya Biosciences (AKYA) United States $0.200B 0.00
Verastem (VSTM) United States $0.199B 0.00
Celcuity (CELC) United States $0.199B 0.00
Gracell Biotechnologies (GRCL) China $0.199B 0.00
Poseida Therapeutics (PSTX) United States $0.196B 0.00
Mesoblast (MESO) Australia $0.195B 0.00
Astria Therapeutics (ATXS) United States $0.192B 0.00
Nuvectis Pharma (NVCT) United States $0.192B 0.00
CorMedix Inc (CRMD) United States $0.190B 0.00
Gritstone Bio (GRTS) United States $0.189B 0.00
Scilex Holding (SCLX) United States $0.188B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.186B 0.00
Sutro Biopharma (STRO) United States $0.185B 0.00
Fate Therapeutics (FATE) United States $0.181B 0.00
Invivyd (IVVD) United States $0.181B 0.00
TELA Bio (TELA) United States $0.179B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.174B 0.00
Ikena Oncology (IKNA) United States $0.166B 0.00
Sagimet Biosciences (SGMT) United States $0.166B 0.00
Gossamer Bio (GOSS) United States $0.163B 0.00
Vaxxinity (VAXX) United States $0.160B 0.00
Tenaya Therapeutics (TNYA) United States $0.159B 0.00
Stoke Therapeutics (STOK) United States $0.159B 0.00
XOMA (XOMA) United States $0.159B 0.00
Prima BioMed (IMMP) Australia $0.158B 0.00
Emergent Biosolutions (EBS) United States $0.155B 0.00
Applied Therapeutics (APLT) United States $0.153B 0.00
LianBio (LIAN) United States $0.153B 0.00
Mersana Therapeutics (MRSN) United States $0.153B 0.00
GENFIT S.A (GNFT) France $0.153B 0.00
Atara Biotherapeutics (ATRA) United States $0.152B 0.00
X4 Pharmaceuticals (XFOR) United States $0.151B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.151B 0.00
Molecular Partners AG (MOLN) Switzerland $0.150B 0.00
Oncolytics Biotech (ONCY) Canada $0.146B 0.00
Selecta Biosciences (SELB) United States $0.145B 0.00
Graphite Bio (GRPH) United States $0.143B 0.00
Vaccitech (VACC) United Kingdom $0.143B 0.00
Vor Biopharma (VOR) $0.139B 0.00
Codexis (CDXS) United States $0.139B 0.00
Seer (SEER) United States $0.138B 0.00
Adocia (ADOCY) France $0.138B 0.00
Rallybio (RLYB) United States $0.131B 0.00
Absci (ABSI) United States $0.131B 0.00
TScan Therapeutics (TCRX) United States $0.131B 0.00
Trevi Therapeutics (TRVI) United States $0.130B 0.00
Design Therapeutics (DSGN) United States $0.129B 0.00
INmune Bio (INMB) United States $0.126B 0.00
PDS Biotechnology (PDSB) United States $0.124B 0.00
Adverum Biotechnologies (ADVM) United States $0.120B 0.00
Puma Biotechnology (PBYI) United States $0.118B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.118B 0.00
InflaRx (IFRX) Germany $0.117B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.116B 0.00
XBiotech (XBIT) United States $0.116B 0.00
Annexon (ANNX) United States $0.111B 0.00
Greenwich LifeSciences (GLSI) United States $0.111B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.110B 0.00
PepGen (PEPG) United States $0.110B 0.00
Theseus Pharmaceuticals (THRX) United States $0.109B 0.00
ChromaDex (CDXC) United States $0.108B 0.00
I-Mab (IMAB) China $0.106B 0.00
Abeona Therapeutics (ABEO) United States $0.105B 0.00
Ocugen (OCGN) United States $0.105B 0.00
Gamida Cell (GMDA) United States $0.103B 0.00
Inovio Pharmaceuticals (INO) United States $0.102B 0.00
Bionano Genomics (BNGO) United States $0.101B 0.00
Sangamo Therapeutics (SGMO) United States $0.101B 0.00
Eton Pharmaceuticals (ETON) United States $0.100B 0.00
Opthea (OPT) Australia $0.100B 0.00
IO Biotech (IOBT) Denmark $0.099B 0.00
NGM Biopharmaceuticals (NGM) United States $0.099B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.099B 0.00
MediciNova (MNOV) United States $0.099B 0.00
Aadi Bioscience (AADI) United States $0.099B 0.00
Rani Therapeutics Holdings (RANI) United States $0.097B 0.00
Immunome (IMNM) United States $0.097B 0.00
Genenta Science S.p.A (GNTA) Italy $0.095B 0.00
BRIACELL THERAP (BCTX) Canada $0.095B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Omega Therapeutics (OMGA) United States $0.093B 0.00
Ocean Biomedical (OCEA) United States $0.093B 0.00
Cue Biopharma (CUE) United States $0.093B 0.00
Immix Biopharma (IMMX) United States $0.090B 0.00
DiaMedica Therapeutics (DMAC) United States $0.088B 0.00
Cara Therapeutics (CARA) United States $0.088B 0.00
Spruce Biosciences (SPRB) United States $0.086B 0.00
Cellectis S.A (CLLS) France $0.086B 0.00
Data Knights Acquisition (DKDCA) United Kingdom $0.085B 0.00
Kodiak Sciences (KOD) United States $0.084B 0.00
Cidara Therapeutics (CDTX) United States $0.083B 0.00
CytomX Therapeutics (CTMX) United States $0.083B 0.00
Jasper Therapeutics (JSPR) United States $0.082B 0.00
C4 Therapeutics (CCCC) United States $0.082B 0.00
Annovis Bio (ANVS) United States $0.080B 0.00
Compugen (CGEN) Israel $0.080B 0.00
ATyr Pharma (LIFE) United States $0.079B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.078B 0.00
Werewolf Therapeutics (HOWL) United States $0.076B 0.00
Kezar Life Sciences (KZR) United States $0.076B 0.00
Genetron Holdings (GTH) China $0.074B 0.00
Affimed (AFMD) Germany $0.073B 0.00
Kronos Bio (KRON) United States $0.073B 0.00
BioAtla (BCAB) United States $0.072B 0.00
Athira Pharma (ATHA) United States $0.071B 0.00
Ocuphire Pharma (OCUP) United States $0.071B 4.00
Tiziana Life Sciences (TLSA) United Kingdom $0.071B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.069B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.069B 0.00
BioXcel Therapeutics (BTAI) United States $0.068B 0.00
Evelo Biosciences (EVLO) United States $0.068B 0.00
Nkarta (NKTX) United States $0.067B 0.00
Enzo Biochem (ENZ) United States $0.067B 0.00
Beyond Air (XAIR) United States $0.067B 0.00
Elicio Therapeutics (ELTX) United States $0.067B 0.00
AVROBIO (AVRO) United States $0.066B 0.00
Adagene (ADAG) China $0.066B 0.00
HCW Biologics (HCWB) United States $0.065B 0.00
G1 Therapeutics (GTHX) United States $0.065B 0.00
Kinnate Biopharma (KNTE) United States $0.063B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.063B 0.00
Alpha Teknova (TKNO) United States $0.063B 0.00
Oncobiologics (OTLK) United States $0.062B 0.00
Spero Therapeutics (SPRO) United States $0.062B 0.00
Prenetics Global (PRE) Cayman Islands $0.060B 1.42
Immunic (IMUX) United States $0.060B 0.00
Eyenovia (EYEN) United States $0.059B 0.00
OKYO Pharma (OKYO) $0.059B 0.00
Shattuck Labs (STTK) United States $0.058B 0.00
Syros Pharmaceuticals (SYRS) United States $0.058B 0.00
Intensity Therapeutics (INTS) United States $0.057B 0.00
Clene (CLNN) United States $0.057B 0.00
Cardiff Oncology (CRDF) United States $0.057B 0.00
Adicet Bio (ACET) United States $0.056B 0.00
Xilio Therapeutics (XLO) United States $0.055B 0.00
Dyadic (DYAI) United States $0.054B 0.00
Turnstone Biologics (TSBX) United States $0.053B 0.00
Clearside Biomedical (CLSD) United States $0.053B 0.00
Connect Biopharma Holdings (CNTB) United States $0.052B 0.00
Instil Bio (TIL) United States $0.052B 0.00
Sorrento Therapeutics (SRNEQ) United States $0.051B 0.00
Longeveron (LGVN) United States $0.051B 0.00
HOOKIPA Pharma (HOOK) United States $0.050B 0.00
Dianthus Therapeutics (DNTH) United States $0.050B 0.00
VTv Therapeutics (VTVT) United States $0.049B 0.00
Solid Biosciences (SLDB) United States $0.048B 0.00
Science 37 Holdings (SNCE) United States $0.047B 0.00
Theratechnologies (THTX) Canada $0.046B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.046B 0.00
Rezolute (RZLT) United States $0.045B 0.00
Quince Therapeutics (QNCX) United States $0.043B 0.00
Celularity (CELU) United States $0.042B 0.00
Leap Therapeutics (LPTX) United States $0.042B 0.00
Galena Biopharma (SLS) United States $0.042B 0.00
Fortress Biotech (FBIO) United States $0.041B 0.00
Dare Bioscience (DARE) United States $0.041B 0.00
Cognition Therapeutics (CGTX) United States $0.040B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.039B 0.00
Kineta (KA) United States $0.039B 0.00
Checkpoint Therapeutics (CKPT) United States $0.038B 0.00
Femasys (FEMY) United States $0.038B 0.00
Precision BioSciences (DTIL) United States $0.037B 0.00
Bolt Biotherapeutics (BOLT) United States $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
Coya Therapeutics (COYA) United States $0.037B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.036B 0.00
VistaGen Therapeutics (VTGN) United States $0.036B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.036B 0.00
Neoleukin Therapeutics (NLTX) United States $0.036B 0.00
Portage Biotech (PRTG) $0.035B 0.00
SAB Biotherapeutics (SABS) United States $0.035B 0.00
Aligos Therapeutics (ALGS) United States $0.035B 0.00
Passage Bio (PASG) United States $0.035B 0.00
Mainz Biomed (MYNZ) Germany $0.034B 0.00
Miromatrix Medical (MIRO) United States $0.034B 0.00
Bionomics (BNOX) Australia $0.034B 0.00
IN8bio (INAB) United States $0.034B 0.00
Lantern Pharma (LTRN) United States $0.033B 0.00
Curis (CRIS) United States $0.032B 0.00
Axcella Health (AXLA) United States $0.031B 0.00
Rain Oncology (RAIN) United States $0.031B 0.00
Biora Therapeutics (BIOR) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.030B 0.00
BeyondSpring (BYSI) United States $0.030B 0.00
NuCana (NCNA) United Kingdom $0.030B 0.00
Telesis Bio (TBIO) United States $0.029B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.029B 0.00
UNITY Biotechnology (UBX) United States $0.029B 0.00
Candel Therapeutics (CADL) United States $0.029B 0.00
Lumos Pharma (LUMO) United States $0.028B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.027B 0.00
Elevation Oncology (ELEV) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Seelos Therapeutics (SEEL) United States $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Evaxion Biotech (EVAX) Denmark $0.024B 0.00
Pluri (PLUR) Israel $0.024B 0.00
Cyclo Therapeutics (CYTH) United States $0.024B 0.00
Evogene (EVGN) Israel $0.023B 0.00
Elutia (ELUT) United States $0.023B 0.00
KALA BIO (KALA) United States $0.022B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.022B 0.00
Forte Biosciences (FBRX) United States $0.022B 0.00
Vincerx Pharma (VINC) United States $0.021B 0.00
GENPREX (GNPX) United States $0.021B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Alzamend Neuro (ALZN) United States $0.020B 0.00
Medicenna Therapeutics (MDNA) Canada $0.020B 0.00
Vascular Biogenics (VBLT) Israel $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
YS Biopharma (YS) China $0.019B 0.92
Sensei Biotherapeutics (SNSE) United States $0.019B 0.00
Purple Biotech (PPBT) Israel $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.018B 0.00
Senti Biosciences (SNTI) United States $0.018B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.018B 0.00
Orgenesis (ORGS) United States $0.018B 0.00
Catalyst Biosciences (CBIO) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Galecto (GLTO) Denmark $0.017B 0.00
Lisata Therapeutics (LSTA) United States $0.017B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.017B 0.00
Freeline Therapeutics Holdings (FRLN) United Kingdom $0.016B 0.00
Virios Therapeutics (VIRI) United States $0.016B 0.00
PHAXIAM Therapeutics S.A (PHXM) France $0.016B 0.00
Mustang Bio (MBIO) United States $0.016B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
AquaBounty Technologies (AQB) United States $0.016B 0.00
Acorda Therapeutics (ACOR) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
ZIVO Bioscience (ZIVO) United States $0.015B 0.00
VBI Vaccines (VBIV) United States $0.015B 0.00
Genetic Technologies (GENE) Australia $0.015B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.014B 0.00
CalciMedica (CALC) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Senesco Technologies (ELOX) United States $0.013B 0.00
Frequency Therapeutics (FREQ) United States $0.013B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.013B 0.00
BioAffinity Technologies (BIAF) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.012B 0.00
Synlogic (SYBX) United States $0.012B 0.00
TFF Pharmaceuticals (TFFP) United States $0.012B 0.00
Biofrontera (BFRI) United States $0.012B 0.00
Landos Biopharma (LABP) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
Pasithea Therapeutics (KTTA) United States $0.012B 0.00
RenovoRx (RNXT) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
Cingulate (CING) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.011B 0.00
Talis Biomedical (TLIS) United States $0.011B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Athersys (ATHX) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
GT Biopharma (GTBP) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
ARAVIVE, INC (ARAV) United States $0.009B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.009B 0.00
Atreca (BCEL) United States $0.009B 0.00
Cadrenal Therapeutics (CVKD) United States $0.009B 0.00
BioCardia (BCDA) United States $0.009B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.009B 0.00
Cohbar (CWBR) United States $0.009B 0.00
Lexaria Bioscience (LEXX) Canada $0.008B 0.00
Trevena (TRVN) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Blue Water Biotech (BWV) United States $0.008B 0.00
Monopar Therapeutics (MNPR) United States $0.008B 0.00
Sunshine Biopharma (SBFM) Canada $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Benitec Biopharma (BNTC) United States $0.008B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.008B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Comera Life Sciences Holdings (CMRA) United States $0.007B 0.00
Biophytis SA (BPTS) France $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Kintara Therapeutics (KTRA) United States $0.007B 0.00
Applied Molecular Transport (AMTI) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
CervoMed (CRVO) United States $0.007B 0.00
Aileron Therapeutics (ALRN) United States $0.007B 0.00
Exicure (XCUR) United States $0.006B 0.43
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
Bellerophon Therapeutics (BLPH) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
TRACON Pharmaceuticals (TCON) United States $0.005B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
PaxMedica (PXMD) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Vaccinex (VCNX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Aptevo Therapeutics (APVO) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.04
Synaptogenix (SNPX) United States $0.004B 0.00
ABVC BioPharma (ABVC) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.004B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Panbela Therapeutics (PBLA) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Aceragen (ACGN) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.25
Dermata Therapeutics (DRMA) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
First Wave BioPharma (FWBI) United States $0.002B 0.06
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Invo BioScience (INVO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
MorphoSys AG (MOR) Germany $0.000B 14.23
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
ARCA Biopharma (ABIO) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
GH Research (GHRS) Ireland $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00